Skip to Content

Rule

New Animal Drugs; Correction of Sponsor's Drug Labeler Codes

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Final rule; technical amendment.

SUMMARY:

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a correction of sponsor's drug labeler code for Pennfield Oil Co.

DATES:

This rule is effective October 26, 2004.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

David R. Newkirk, Center for Veterinary Medicine (HFV-100), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-6967, e-mail: david.newkirk@fda.gov.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

FDA has found that the animal drug regulations do not reflect the correct sponsor's drug labeler code for Pennfield Oil Co. Accordingly, the agency is amending the regulations in 21 CFR 510.600, 520.445b, 520.1660d, 522.1660a, 558.76, 558.78, 558.128, 558.140, 558.145, 558.195, 558.355, 558.450, 558.550, 558.600, 558.625, and 558.630 to correct this error.

This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

Start List of Subjects

List of Subjects

and 522

End List of Subjects Start Amendment Part

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine,

End Amendment Part Start Part

PART 510—NEW ANIMAL DRUGS

End Part Start Amendment Part

1. The authority citation for

End Amendment Part Start Authority

Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

End Authority Start Amendment Part

2. Section 510.600 is amended in the table in paragraph (c)(1) in the entry for “Pennfield Oil Co.” by removing “053389” and by adding in its place “048164”; and in the table in paragraph (c)(2) by removing the entry for “053389” and by adding in numerical sequence an entry for “048164” to read as follows:

End Amendment Part
Names, addresses, and drug labeler codes of sponsors of approved applications.

(c) * * *

(1) * * *

Firm name and addressDrug labeler code
*    *    *    *    *
Pennfield Oil Co., 14040 Industrial Rd., Omaha, NE 68144048164
*    *    *    *    *

(2) * * *

Drug labeler codeFirm name and address
*    *    *    *    *
048164Pennfield Oil Co., 14040 Industrial Rd., Omaha, NE 68144
*    *    *    *    *
Start Part

PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS

End Part Start Amendment Part

3. The authority citation for

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b.

End Authority
[Amended]
Start Amendment Part

4. Section 520.445b is amended in paragraph (b) by removing “053389” and by adding in its place “048164”.

End Amendment Part
[Amended]
Start Amendment Part

5. Section 520.1660d is amended in paragraph (b)(6) by removing “053389” and by adding in its place “048164”.

End Amendment Part Start Part

PART 522—IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS

End Part Start Amendment Part

6. The authority citation for

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b.

End Authority
[Amended]
Start Amendment Part

7. Section 522.1660a is amended in paragraph (b) by removing “053389” and by adding in its place “048164”.

End Amendment Part Start Part

PART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS

End Part Start Amendment Part

8. The authority citation for

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b, 371.

End Authority
[Amended]
Start Amendment Part

9. Section 558.76 is amended in the table in paragraph (d)(1)(iv) in the “Limitations” and “Sponsor” columns by removing “053389” and by adding in its place “048164”.

End Amendment Part Start Amendment Part

10. Section 558.78 is amended by revising paragraphs (a) and (b); in the table in paragraph (d)(1) by redesignating paragraphs (d)(1)(ii) through (d)(1)(vi) as paragraphs (d)(1)(iii) through (d)(1)(vii); and by revising paragraph (d)(1)(i); and by adding new paragraph (d)(1)(ii) to read as follows:

End Amendment Part
Bacitracin zinc.

(a) Specifications. Type A medicated articles containing bacitracin zinc equivalent to 5, 10, 25, 40, or 50 grams per pound bacitracin.

(b) Approvals. See sponsors in § 510.600(c) of this chapter for uses as follows:

(1) No. 046573: 10, 25, 40, and 50 grams per pound for uses as in paragraph (d) of this section.

(2) No. 048164: 5 and 50 grams per pound for use as in as in paragraph (d)(1)(i) of this section.

(d) * * *

(1) * * *

Start Printed Page 62407
Bacitracin zinc in grams per tonCombinations in grams per tonIndications for useLimitationsSponsor
(i) 4 to 50Chickens: for increased rate of weight gain and improved feed efficiencyGrowing chickens046573 048164
(ii) 4 to 50Turkeys and pheasants: for increased rate of weight gain and improved feed efficiencyGrowing turkeys and pheasants046573
*         *         *         *         *         *         *
[Amended]
Start Amendment Part

11. Section 558.128 is amended in paragraph (b)(1) by removing “053389” and by adding in its place “048164”; and in the tables in paragraphs (e)(1), (e)(2), (e)(3), (e)(4), and (e)(5) in the “Sponsor” column by removing “053389” wherever it appears and by adding in its place “048164”.

End Amendment Part
[Amended]
Start Amendment Part

12. Section 558.140 is amended in paragraph (a) by removing “053389” and by adding in its place “048164”.

End Amendment Part
[Amended]
Start Amendment Part

13. Section 558.145 is amended in paragraph (a)(2) by removing “053389” and by adding in its place “048164”.

End Amendment Part
[Amended]
Start Amendment Part

14. Section 558.195 is amended in the table in paragraph (e)(2)(iii) in the “Limitations” and “Sponsor” columns by removing “053389” and by adding in its place “048164”.

End Amendment Part
[Amended]
Start Amendment Part

15. Section 558.355 is amended in paragraph (f)(1)(xiv)(b) by removing “053389” and by adding in its place “048164”.

End Amendment Part
[Amended]
Start Amendment Part

16. Section 558.450 is amended in paragraph (a)(2) by removing “053389” and by adding in its place “048164”; in the table in paragraphs (d)(1)(i), (d)(1)(v), (d)(1)(vii), and (d)(1)(viii) in the “Sponsor” column by removing “053389” wherever it appears and by adding in its place “048164”; and in the table in paragraph (d)(1)(ix) in the “Limitations” column by removing “053389” wherever it appears and by adding in its place “048164”.

End Amendment Part Start Amendment Part

17. Section 558.550 is amended in paragraphs (d)(1)(xv)(

End Amendment Part
Salinomycin.

(a) Specifications. Type A medicated articles containing 30 or 60 grams of salinomycin activity per pound (as salinomycin sodium biomass).

(b) Approvals. See sponsors in § 510.600(c) of this chapter for use as in paragraph (d) of this section:

(1) No. 046573 for use as in paragraph (d) of this section.

(2) No. 057926 for use as in paragraphs (d)(1)(i), (d)(1)(iii) through (d)(1)(xvi), (d)(2)(i), and (d)(3)(i) of this section.

(3) No. 048164 for use as in paragraphs (d)(1)(xv) and (d)(1)(xvi) of this section.

[Amended]
Start Amendment Part

18. Section 558.600 is amended in the table in paragraph (e)(1)(iii) in the “Limitations” and “Sponsor” columns by removing “053389” and by adding in its place “048164”.

End Amendment Part
[Amended]
Start Amendment Part

19. Section 558.625 is amended in paragraph (b)(89) by removing “053389” and by adding in its place “048164”.

End Amendment Part
[Amended]
Start Amendment Part

20. Section 558.630 is amended in paragraph (b)(10) by removing “053389” and by adding in numerical sequence “048164”.

End Amendment Part Start Signature

Dated: October 14, 2004.

Steven D. Vaughn,

Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.

End Signature End Supplemental Information

[FR Doc. 04-23854 Filed 10-25-04; 8:45 am]

BILLING CODE 4160-01-S